High-quality ARA-290 Lyophilized Powder Complete Batch COA Report N-Terminal Pyr-Glu Modified P

High-quality ARA-290, also known as Cibinetide, is a synthetic 11-amino-acid peptide derived from the tissue-protective domain of human erythropoietin (EPO), with N-terminal pyroglutamic acid modification to enhance molecular stability. It is manufactured via mature solid-phase peptide synthesis and reversed-phase high-performance liquid chromatography purification, featuring accurate amino acid sequence, reliable batch-to-batch uniformity and exclusive selectivity for the heterodimeric innate repair receptor (EPOR/CD131 IRR complex) while completely lacking affinity for the homodimeric EPO receptor that triggers erythropoiesis. Distinct from full-length EPO, ARA-290 activates tissue repair, anti-inflammatory and anti-apoptosis signaling pathways without stimulating red blood cell proliferation, eliminating hematopoietic side effects and thrombotic risks in research models. According to public academic literatures, this peptide is extensively applied in in vitro neuronal/endothelial cell culture, IRR receptor binding affinity detection, inflammatory cytokine biochemical assays, as well as in vivo animal model experiments focusing on diabetic neuropathy, small fiber neuropathic pain, chronic inflammation, microvascular injury, organ cytoprotection and autoimmune disorder mechanism research. Every production batch undergoes strict full-index quality inspection, complete COA, HPLC and mass spectrometry test documents can be provided to support laboratory filing and customs clearance for universities, biotech research institutions and pharmaceutical R&D laboratories. nt.

• Boosts cellular energy & mitochondrial vitality — strengthens skin’s self-repair capacity
• Powerful antioxidant — neutralizes free radicals, reduces oxidative stress & photoaging
• Anti-aging & firming — improves elasticity, reduces fine lines and wrinkles
• Repairs damaged skin — calms irritation, refines texture, restores radiance
• Protects cell membranes — stabilizes cardiolipin, delays cellular senescence
• Deep hydration & revitalization — enhances skin’s moisture retention and youthful glow

Hong Kong Bosen Peptide Research & Development Co., Ltd. is a world-leading manufacturer and supplier of peptides and pharmaceutical raw materials, specializing in the chemical industry.

Our main products include peptide products and pharmaceutical raw materials. We possess strong research and development capabilities, exquisite synthesis technologies, and advanced quality control methods. We actively carry out joint ventures and cooperation with major enterprises and manufacturers, and adhere to the concept of industrial development to serve society and users. We always adhere to market demand orientation, and continuously develop new high-tech chemical products and pharmaceutical intermediates.

I am fully confident in the quality of our products, and many overseas customers have spoken highly of them after receiving the goods. Our products are of excellent quality, and we solemnly promise door-to-door delivery service worldwide. We provide high-quality after-sales service aimed at customer satisfaction.

High-quality Semaglutide lyophilized polypeptide powder, purity ≥98%, long-acting lipid-modified GLP-1 receptor agonist with strong albumin binding property. Available in 1mg/5mg vials with low endotoxin, suitable for diabetes, obesity and hepatic lipid metabolism research. Full test COA supplied. For laboratory research use only.

This product is exclusively laboratory research raw material, which cannot be classified as medicine, health supplement or cosmetic ingredient. All descriptive contents are excerpted from public academic papers, without any statement of medical curative efficacy or weight-loss effect claims. All purchasers must strictly abide by local chemical import and export laws, biochemical material safety management regulations, and bear full responsibility for product storage, experimental operation and usage scope.